S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
NASDAQ:MGRX

Mangoceuticals (MGRX) Stock Price, News & Analysis

$0.24
-0.03 (-11.02%)
(As of 04/12/2024 ET)
Today's Range
$0.23
$0.26
50-Day Range
$0.15
$0.44
52-Week Range
$0.14
$3.18
Volume
459,201 shs
Average Volume
1.13 million shs
Market Capitalization
$5.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MGRX stock logo

About Mangoceuticals Stock (NASDAQ:MGRX)

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It provides erectile dysfunction and hair growth products under the Mango and Mango GROW brand names. The company also offers direct-to-clinics solutions comprising PRIME, an oral testosterone replacement therapy (TRT) prescription product by doctors and medical practitioners to their patients directly from their offices, clinics, and brick and mortar locations. It sells its products through its online website at mangorx.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

MGRX Stock Price History

MGRX Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Mangoceuticals, Inc. (MGRX)
Why Is Mangoceuticals (MGRX) Stock Down 33% Today?
See More Headlines
Receive MGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mangoceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/14/2024
Next Earnings (Estimated)
7/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MGRX
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-9,210,000.00
Net Margins
-1,260.81%
Pretax Margin
-1,260.19%

Debt

Sales & Book Value

Annual Sales
$730,000.00
Book Value
$0.04 per share

Miscellaneous

Free Float
12,660,000
Market Cap
$5.72 million
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Jacob D. Cohen (Age 45)
    CEO & Chairman
    Comp: $70k
  • Mr. Jonathan Arango (Age 29)
    President, Secretary & Director
    Comp: $50k
  • Mr. Eugene M. Johnston (Age 60)
    Chief Financial Officer
  • Ms. Amanda Elizabeth Hammer (Age 39)
    Chief Operating Officer

MGRX Stock Analysis - Frequently Asked Questions

How have MGRX shares performed in 2024?

Mangoceuticals' stock was trading at $0.2769 at the start of the year. Since then, MGRX shares have decreased by 12.5% and is now trading at $0.2423.
View the best growth stocks for 2024 here
.

Are investors shorting Mangoceuticals?

Mangoceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 692,100 shares, an increase of 364.2% from the March 15th total of 149,100 shares. Based on an average trading volume of 1,070,000 shares, the days-to-cover ratio is presently 0.6 days. Currently, 5.3% of the shares of the company are sold short.
View Mangoceuticals' Short Interest
.

When is Mangoceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024.
View our MGRX earnings forecast
.

When did Mangoceuticals IPO?

Mangoceuticals (MGRX) raised $5 million in an initial public offering on Tuesday, March 21st 2023. The company issued 1,300,000 shares at $4.00 per share. Boustead Securities acted as the underwriter for the IPO.

How do I buy shares of Mangoceuticals?

Shares of MGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MGRX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners